Pharmaceutical Industry in
Reinach BL

Protzek Biotec GmbH

Since 2003 · 11–20 empl.

The core activity of Protzek is the development, production and distribution of objective test and analysis systems for medical, police and forensic applications, particularly in the fields of toxicology and virology, with a focus on sustainable and environmentally friendly products.

Thermo Fisher Diagnostics AG

Since 2006 · 101–500 empl.

Thermo Fisher Diagnostics AG supplies diagnostic instruments, reagents, consumables, software and related services for clinical laboratories and life‑science research. Its portfolio includes laboratory equipment and analytical systems for sample and material characterization, chemical analysis and clinical diagnostics.

Baliopharm AG

Since 2007 · 1–10 empl.

Baliopharm AG is a biotechnology company developing antibody therapeutics for chronic liver diseases, immune-mediated inflammatory diseases and oncology. Its portfolio includes monoclonal antibodies and antibody-derived formats such as monovalent and bispecific constructs designed for targeted selectivity.

Thermo Fisher Scientific (Schweiz) AG

Since 2008 · 101–500 empl.

Thermo Fisher Scientific (Schweiz) AG supplies scientific instruments, reagents, consumables, software and services for research, diagnostics, biopharma and industrial laboratories. Its portfolio includes laboratory equipment, antibodies and assays, contract development and manufacturing (CDMO/CRO) services, instrument support and lab informatics solutions.

Valerius Biopharma AG

Since 2017 · 1–10 empl.

Valerius Biopharma AG develops biosimilars and manages a portfolio of orphan and non‑orphan candidates, conducting R&D on cell lines, process development and extensive analytical characterization.

Premark Pharma GmbH

Since 2018 · 21–50 empl.

Premark Pharma GmbH develops and commercialises topical treatments for inflammatory diseases of the skin, eye, mucosae and mucocutaneous surfaces. Its lead ophthalmic assets include pimecrolimus formulations such as PMP2207 (an ointment for blepharitis) and PMP1606 (a liquid suspension for dry eye), with Phase 3 programmes planned and regulatory approvals sought in the EU and US.

Gigabases Switzerland AG

Since 2018 · 1–10 empl.

Gigabases Switzerland AG operates a web-based platform for 3D protein design and ordering sequence-verified expression plasmids. The platform provides a database of over 214 million protein 3D structures, tools to modify proteins at the amino-acid level, and algorithms that translate designs into ready-to-order plasmids for mammalian, viral, or bacterial expression.

ESN Life Sciences GmbH

Since 2011 · 1–10 empl.

SunRegen Healthcare AG

Since 2017 · 1–10 empl.

The core activity of SunRegen Healthcare AG is the development of medications for the treatment of neurodegenerative diseases, particularly retinal neurodegenerations such as Retinitis Pigmentosa, age-related macular degeneration and glaucoma, as well as central nervous system neurodegenerations such as Alzheimer's, Huntington's, Parkinson's and ALS. The company focuses on the development of oral therapeutics that inhibit neuronal apoptosis and exhibit neuroprotective effects.

Allpack Group AG

Since 1995 · 11–20 empl.·3.5(11)

The company's core activity is the manufacture and packaging of pharmaceutical products, particularly primary and secondary packaging of medicinal products, in compliance with GMP standards (Good Manufacturing Practice) and taking into account environmental, social and corporate governance aspects (ESG).

ZAMAPHARMA AG

Since 2025 · 1–10 empl.

ZAMAPHARMA AG develops digital biotech solutions related to the treatment of metastatic cancer. The website presents the company as a digital biotech business and provides a contact form.

Lindau Medizinalprodukt

Since 2018 · 1–10 empl.